Submit Deal

TILRAY INC

Summary

Tilray operates as a pharmaceutical company. The Company develops cannabis based medicines, drugs, drops, and oil products. Tilray serves clients worldwide.

Deals Overview

Total Deals5

Valued Deals3

Total Value£ 3.23 B

Avg. Deal Size£ 1.08 B

Market Context

Senior Management

Brendan Kennedy
President and CEO
Irwin D. Simon
CEO
Mark Castaneda
CFO

Sort

brendan kennedy

President and CEO at TILRAY INC

Manager

Deals

£ 3.16 B

Total Value

mark castaneda

CFO at TILRAY INC

Manager

Deal

n/a

Total Value

chrissy roebuck

Communications Director at TILRAY INC

Manager

Deal

n/a

Total Value

andrew pucher

Chief Corporate Development Officer at TILRAY INC

Manager

Deal

£ 68 M

Total Value

amy bonwick

Communications Director at TILRAY INC

Manager

Deal

£ 2.92 B

Total Value

irwin d. simon

CEO at TILRAY INC

Manager

Deal

n/a

Total Value

berrin noorata

Media Contact at TILRAY INC

Manager

Deal

n/a

Total Value

carl merton

CFO at TILRAY INC

Manager

Deal

n/a

Total Value

By continuing, you agree to our Terms & Conditions and our Data Privacy Policy